Show simple item record

dc.contributor.authorKassamali, Z
dc.contributor.authorPrince, RA
dc.contributor.authorDanziger, LH
dc.contributor.authorRotschafer, JC
dc.contributor.authorRhomberg, PR
dc.contributor.authorJones, RN
dc.date.accessioned2016-05-12T22:12:03Z
dc.date.available2016-05-12T22:12:03Z
dc.date.issued2015-12
dc.identifier.bibliographicCitationKassamali, Z., Prince, R. A., Danziger, L. H., Rotschafer, J. C., Rhomberg, P. R. and Jones, R. N. Microbiological assessment of polymyxin B components tested alone and in combination. Antimicrobial Agents and Chemotherapy. 2015. 59(12): 7823-7825. DOI: 10.1128/AAC.01021-15.en_US
dc.identifier.issn0066-4804
dc.identifier.urihttp://hdl.handle.net/10027/20632
dc.descriptionThis is a copy of an article published in Antimicrobial Agents and Chemotherapy © 2015 American Society for Microbiology Publications.en_US
dc.description.abstractWe investigated the antimicrobial activity of four polymyxin B components, B1, B2, B3, and isoleucine (Ile)-B1, individually and in combination. B3 was the most active agent against all organisms tested except Acinetobacter baumannii, for which Ile-B1 was most active. One combination met the criteria for synergy, B3 plus Ile-B1. No combinations exhibited antagonism. The dominant components of polymyxin B products (B1 and B2) were associated with the lowest probability of improved antibacterial activity when combined.en_US
dc.publisherAmerican Society for Microbiologyen_US
dc.titleMicrobiological Assessment of Polymyxin B Components Tested Alone and in Combination.en_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record